Trials / Completed
CompletedNCT06440252
Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults
The Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults: a Randomised, Double-blind, Placebo-controlled Crossover Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- RDC Clinical Pty Ltd · Industry
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo-controlled, 2 arm crossover study conducted over 11 weeks, with participants randomised to a product for 4 weeks, followed by a 3-week washout period before completing the second product for 4 weeks, to study the effectiveness of a grape seed extract on circulatory measures in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Grape Seed Extract | One daily dose of 1 capsule containing 600mg grape seed extract |
| DRUG | Maltodextrin | One daily dose of 1 capsule |
Timeline
- Start date
- 2024-10-31
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-06-03
- Last updated
- 2026-03-06
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06440252. Inclusion in this directory is not an endorsement.